Make technologies, products, and markets readable.
We connect technology, company and market data so you can identify opportunities and make informed decisions.
- Patent documents
- 213M+
- across 172 patent offices
- Company records
- 87M+
- financial data across 46 countries
- Publications
- 465M+
- journals, repositories and preprints
Everything starts with the data. mar:lean reads the three together.
Every point on the globe is a patent document, a company record or a publication. The figures count what the platform can query, not what it has analysed so far. mar:val combines all three to value technologies and their markets. mar:ker drafts from the invention disclosure and the prior art you upload.
Data coverageFrom technology data to capital.
Reading technologies through patents.
Patents show what a technology can do. We read technologies through their IP rights and turn inventions into robust, filing-ready applications, from the first invention disclosure to the granted and defended patent.
- Patent drafting
- Claim analysis
- Office action responses
- Prior-art search
- Freedom-to-operate
- Divisional applications
- Oppositions & proceedings
Valuing them in the market.
We measure what a technology is worth in the market. The result is a valuation you can explain to investors, buyers and the board, with its data, methods and assumptions laid out.
- Pre-screening
- Technology valuation
- Market insights
- Competitive analysis
- Buyer matchmaking
- Business development
- M&A market analysis
Financing development and growth.
Our finance arm supports companies through development and growth. It uses IP rights as the basis for financing, from IP-backed planning and company formation to the right funding for the next phase.
- Financial planning
- IP-backed financing
- Startup formation
- Growth strategy
- Investment signals
- Grant scoutingSOON
Technology valuation & market analysis for informed decisions.
Understand what your technology is worth and where your company stands in the market. Inform investment, licensing and sale decisions with data and transparent assumptions.
Explore mar:val- Your technology · Optical sensing
- Mapped to markets
- Applications · Automotive · Medtech
- Market sized
- Market · $2.4B · +11% / yr
- Relief from royalty
- Value · $4.2M
- Buyers ranked
- Medtronix · 92%
- Biosense AG · 78%
- Coredex · 64%
You've developed a technology. You don't know what it's worth, or who would pay for it.
mar:val gives you a value you can justify and a ranking of the companies with a reason to buy your technology.
- Buyers ranked by how well your technology fits them.
- Six score components and the model's confidence.
- Contacts with a name and a role.
- Target · Novalis GmbH
- Checked
- Technology · Optical sensing
- Market position · Ranking 61 / 100
- Strength · Partner & out‑license
- Filed accounts
- Value · 2 methods · $23–31M
- Funding · M&A
- Capital flows · Series B · 2024
- Gaps listed
- Evidence gap · FY 2025 accounts
You're about to put money in. The pitch deck is not evidence.
mar:val checks the target's technology, balance sheet and market position against registers, filed accounts and patent data, and tells you where the evidence runs out.
- A 0–100 ranking, and the strength of its technology set against the resources to carry it.
- A value range from two methods, one from the market and one from company revenue. How far they lie apart shows how firm the value is.
- Funding and acquisition history, with sources.
- Your portfolio · 6 technology fields
- Technology clusters
- Optical sensing · $2.4M
- Signal processing · $0.9M
- Housings · $0.3M
- Cost to keep
- Costs ahead · $0.4M
- Value after costs · −$0.1M
- Scenario
- What-if · Sell the field
Which of your technologies are worth what they cost to keep?
mar:val values each technology in its own market and sets the cost of keeping it protected against that value. You can then test what selling or reassigning a field does to the total.
- Three valuation approaches side by side, so you see how far they lie apart.
- Protection costs from the offices' real fee schedules.
- Scenarios that never touch the real data.
- Your field · Optical sensing
- Lifecycle
- Market launch · 2009
- Growth · +11% / yr
- Maturity · now · $2.4B · 48 players
- Saturation · Ahead
Is this field still worth entering, and who already owns it?
mar:val shows the size, pace and maturity of the technology field, who files and manufactures in it, and where in the lifecycle you would be entering.
- A lifecycle curve instead of a growth promise.
- Revenue by country, with the growth multiple per country.
- Research institutes reported separately from industry.
- Your product · Optical sensor
- Features listed
- Features · 6 mapped
- Kaltex Systems · High · 2034
- Orbis Medical · Medium · 2031
- Design around
- Feature C · Redesigned
- Monitor · Until 2031
- Path to market
- Market entry · DE · FR · US
You're about to launch. Could anyone block the product?
mar:val checks, feature by feature, who could block your product, and suggests design-arounds. It also states what the screen does not cover.
- Each party that could block you, mapped to your product's features.
- An unverified legal status never yields "low risk".
- A design-around for every high and medium finding.
- Your invention · Optical aperture
- Relief from royalty
- Value in its market · $2.4M
- Required revenue
- Partner must earn · $11.8M
- Partners ranked
- Medtronix · 92%
- Biosense AG · 78%
- Institut Helvet · Academia
- Decision-makers
- Head of R&D · By name
You've researched something new. Who brings it to market with you?
mar:val shows what each of your inventions is worth in its market and what a partner would need to earn with it. It names the companies best placed to take it to market, down to the people in them.
- Each invention valued in its market, with the revenue a partner would need.
- Partners ranked by measured fit, with evidence per candidate.
- Decision-makers at the partner, by name and role.
Draft patents. Respond to office actions.
mar:ker supports patent attorneys and in-house IP teams with AI for patent applications and office action responses. You review and edit the text and make the professional decisions.
Explore mar:ker- Invention disclosure · Your documents
- Essential features
- Feature a · Support element (12)
- Feature b · Control module (14)
- Feature c · Damping layer (16)
- Claim draft
- Claim 1 · Sensor unit (10)
- Claim tree
- Claims 2–6 · Dependent on 1
- Claim 7 · Method
- Description · Per claim
Every application starts with a blank page.
Claims and description are generated as a cleanly structured AI draft. Start with a reviewable version instead of a blank page.
- Invention disclosure, prior art, and your firm's reference documents. You decide per document what the AI may use.
- Claims, description, and abstract emerge as a structured draft, distinguished from the prior art and in your style.
- You review, adjust, and export a filing-ready PDF per office: DPMA, EPO, USPTO, and PCT.
- D1 · EP 3 812 004 A1 · High
- D2 · US 2019/0194 A1 · Medium
- D3 · Journal article · Low
- Disclosed in
- Feature a · Known · D1
- Feature b · Known · D1–D3
- Feature c · New
- Preamble
- Claim 1 · Characterised by c
- Prior art section · By relevance
Which features of your invention are new?
mar:ker incorporates relevant prior publications and distinguishes your invention from them, so it is clear from the outset what is new.
- You decide which steps may use each document.
- mar:ker lists each distinguishing feature with its technical effect.
- The description starts with the closest prior art.
- Draft · Sensor unit (10)
- Checked across sections
- 24 terms · Consistent
- Checked per figure
- 18 reference signs · Drawn = described
- Export
- DPMA · A4 · German
- EPO · A4 · English
- USPTO · US Letter · English
- PCT · A4 · WIPO rules
Small inconsistencies, expensive consequences.
Reference signs and technical terms are checked across the entire document. Contradictions that could delay examination are flagged in advance.
- mar:ker checks, figure by figure, that every drawn reference sign is described.
- Each term keeps the same wording throughout the document.
- One filing-ready PDF per office: DPMA, EPO, USPTO and PCT.
- Office action · Inventive step
- Objection read
- Cited · D1 · Claim 1
- Drafted
- Response · AI draft
- You decide
- Your review · Refined
- Submission · By you
The examiner has objected. The deadline is running.
mar:ker writes a first draft of your response. You review and edit it, and you decide what gets filed.
How it worksDEMO REQUEST
See the tools on your own case.
Thirty minutes, no obligation. We show mar:val on a report from your technology field, mar:ker on an invention disclosure from your practice, or both in one session.